Department of Biomedical Informatics

Team explores diabetes drug’s ability to treat RSV infection

A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways. A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease.

Employees’ use of My Health at Vanderbilt encouraged

Vanderbilt University Medical Center employees who are also patients are encouraged to enroll in My Health at Vanderbilt, the online portal for Vanderbilt Health.

Launch event helps introduce ‘All of Us’ initiative to Nashville

On Sunday, May 6, Nashville played an important role in the nationwide launch of “All of Us,” the National Institutes of Health’s (NIH) research program that aims to collect the health information of 1 million or more research participants.

Vanderbilt plays major role in nationwide “All of Us” research program — press release

Gene study spots clues to heart risk for statin patients

A Vanderbilt-led research team has discovered genetic variations that increase the risk of heart attack even when patients are receiving a statin drug like Lipitor or Crestor to lower their blood cholesterol.

Event set to launch ‘All of Us’ personalized medicine initiative

The All of Us Research Program, which aims to accelerate the prevention and treatment of illness through precision medicine with the help of a million or more research participants across the United States, officially opens for national enrollment Sunday, May 6.

1 17 18 19 20 21 26